Meeting
2020 ASCO Virtual Scientific Program
Targetable immune checkpoint molecules may be significantly differentially expressed in minority ethnicities.
Authors
Jacob J. Adashek
University of South Florida, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Jacob J. Adashek , Christopher Szeto , J. Zack Sanborn , Sandeep K. Reddy , Amir A. Toor , Stamatina Danielides , Steven Smith , Steven R. Grossman , Charles V Clevenger , Anthony Faber , Andrea Ferreira-Gonzalez , Sosipatros Alexandros Boikos
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 38: 2020 (suppl; abstr 3576)
DOI
10.1200/JCO.2020.38.15_suppl.3576
Abstract #
3576
Poster Bd #
306
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai
Poster
2017 ASCO Annual Meeting
Gene expression analysis of tumor biopsies from a trial of durvalumab to identify subsets of NSCLC with shared immune pathways.
First Author: Katie Streicher
Poster
2022 ASCO Annual Meeting
Comprehensive transcriptomic analysis of immune checkpoint markers in a pancancer cohort: Implications for response and resistance.
First Author: Hirotaka Miyashita
Poster
2019 ASCO Annual Meeting
Tumor mutation burden and PD-L1 expression in SDH/FH mutated solid tumors.
First Author: Leylah Drusbosky